Get Involved in Diabetes Research
Looking to make a difference in the world of type 1 diabetes? Consider signing up for a clinical trial! Getting involved in studies helps improve diabetes care for all. Some studies are simply online surveys, where others are testing out new diabetes devices or medications.
Listed below are studies that are currently recruiting participants, with links where you can contact the study coordinator or center. You can also check out clinicaltrials.gov and search for “type 1 diabetes” to find all active clinical trials in the U.S.
- NEW: Researchers at Stanford University are looking for teens with T1D ages 12-19 and their caregivers to participate in The Insul-In This Together Study about supporting teens with T1D and their families. This study involves attending six weekly 30-minute video sessions, filling out online surveys, and providing A1c results and CGM data to the research team. Participants in this study receive Stanford’s parent-teen program for free, and can receive up to $100 in Amazon gift cards at the end of the study. See if you are eligible.
- NEW: HPCs: The ISPAD-JENIOUS group is conducting a research study to evaluate diabetologists and healthcare professionals' confidence and knowledge on the issue of dermatological complications, especially contact dermatitis, caused by technological devices used for the management of diabetes in children and adolescents with T1D. For more information, and to apply, click here.
- NEW: A 2nd year PhD student at Rosalind Franklin University of Medicine and Science is conducting a study that seeks to understand more about the relationships young adults (age 18-29) with type 1 diabetes have with their medical providers, and how these relationships impact their diabetes management. If you are between the ages of 18-29, have type 1 diabetes, have seen your endocrinologist in the last year, and can read English please consider participating! Learn more about the study and take the survey.
NEW: Wayne State University’s Department of Family Medicine is offering a mobile health (mHealth) study for young adults ages 16-25 years old diagnosed with type 1 diabetes (T1D). This study aims to see if T1D management and health outcomes are improved by using cellphones. Click here to learn more and to see if you are eligible. Please contact the research team at [email protected] or 313-731-2814 for more information.
- Albert Einstien College of Medicine and the Ferkauf Graduate School of Psychology are running a new research study, The ReDUCe Study. This new program for young adults with T1D aims to reduce diabetes distress, increase emotional-well being, and improve blood sugar ccontrol This is a 12 month fully virtual study. Learn more.
- Are you the parent of an emerging adult (aged 15-25) with type 1 diabetes? The purpose of this study is to identify desired types and mechanisms of support for parents during their emerging adult’s transition to adulthood with T1D. Click here to access the confidential online screening questionnaire. Participants who complete both the survey and the focus group will be entered into a drawing to win a $100 Amazon.com e-gift card!
- Join a Dartmouth College study and get an app that may help you manage your diabetes! Inviting young adults aged 19-29 years old who are diagnosed with type 1 diabetes for 18 months or more. Participants will be compensated for participating. Click here to learn more and complete the eligibility survey!
- Researchers at Children’s National Hospital and the George Washington University are conducting a research study about quality of life in youth 11-17 years old with type 1 diabetes. Youth who participate will also be asked to attend a 30-minute virtual meeting (via Zoom Telehealth), during which they will be asked to complete questionnaires about living with diabetes, diabetes management, and their intake of foods and beverages containing certain sweeteners. Compensation is provided. If you are interested in hearing more about this study, please contact us by calling or texting us at (202)-618-2207 or emailing us at [email protected].
- Market Research Study: The purpose of this research is to evaluate the messages and information that will be included in educational materials being developed for the T1D community. Research will be conducted through a 60-minute web-assisted one-on-one interview, and selected participants will be compensated for their time. If you or one of your family members have been screened and tested positive for 2 or more T1D-related autoantibodies, please consider filling out this form.
- Having a hard time finding reliable Diabetes Care and information? Help researchers at MyDER Inc. and The University of North Georgia create an app that will give people with type 1 diabetes easy access to Diabetes Educators and helpful diabetes resources by taking their survey. Caregivers take this survey. Patients over 18 take this survey.
- The purpose of the VX-880 Islet Cell Infusion study sponsored by Vertex Pharmaceuticals is to evaluate the safety, tolerability, and effectiveness of an investigational islet cell infusion called VX-880. The goal of this infusion is to provide replacement cells for the ones that have been lost or don’t work properly in people with diabetes. Participants may be compensated financially for study-related time and reimbursed for travel. Learn more and see if you qualify.
- The Gladiator Study was designed to further evaluate whether ladarixin is effective in preserving β-cell function and slowing down the progression of T1D in patients with a more severe disease presentation. This study is for patients diagnosed with T1D within 100 days from first insulin administration who are 14-45 years old. Learn more. For questions, contact Hali Broncucia at [email protected].
- The MAS-1 Study is working to prove that MAS-1 vaccine is safe and promotes anti-inflammatory pathways while decreasing auto-inflammatory actions in the body. This study is looking for patients diagnosed with T1D within previous 2 years who are 18-45 years old. Learn more. For questions, contact Hali Broncucia at [email protected].
- Join the ATTEMPT study at SickKids! Teens ages 12 - 18 years with type 1 #diabetes (T1D) could receive a new oral medication taken with insulin to see if it helps prevent complications and improve glycemic control. This study is being conducted in Ontario, Canada. To participate, reach out to [email protected].
- MannKind Corporation has announced that the INHALE-1 Study of Afrezza® has officially begun enrollment for those aged 4-17 living with T1D/T2D. Afrezza (insulin human) Inhalation Powder is the only inhaled ultra rapid-acting mealtime insulin and is FDA-approved for adults (18+) with T1D or T2D. The multi-center study will assess the efficacy and safety of Afrezza vs. multiple daily injections of insulin, both in combination with basal insulin. For more details about the study and if your child may be eligible, please visit go.afrezza.com/INHALE1.
- The Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) study is seeking participants for our research study about barriers to uptake of continuous glucose monitoring (CGM) in adults with type 1 diabetes. Learn more here.
- D-COPES stands for Diabetes - Connecting Online Peers to Enhance Support. If you are eligible and agree to be in this study, you will be matched to a peer who will guide you through diabetes-specific online resources to better support you and your diabetes. Click here to review the study to see if you are eligible.
- Little is known about how families manage diabetes when multiple family members have type 1 diabetes. Such families may have strategies they share that make living with T1D easier. The University of Utah is conducting a multi T1 study - get more information here!
- The Insul-In This Together Study is a Stanford research study recruiting teens ages 12-19 with Type 1 Diabetes and their parents to participate a family-based program. The program is six weekly 30-minute video sessions and discusses topics like parental monitoring and involvement and parent-teen conflict. Data collection includes online surveys and sharing CGM data and A1c results. If you think you might be interested, please complete the online screening at: https://redcap.link/IITT or email their team at: [email protected].